Taiwan medical device registration timeline
Source-linked clocksTaiwan Food and Drug Administration (TFDA) review clocks and end-to-end planning ranges, using the 3-class (I, II, III) classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class I(Registration) Statutory handling period 80 calendar days (initial review 47 + post-supplement review 33) for the non-counter filing route | 80 days | 3-7 months | — | Verified |
| Class II(Registration) Statutory handling period 140 calendar days (initial review 75 + post-supplement review 65) | 140 days | 9-14 months | 6-9 months | Verified |
| Class III(Registration with clinical data) Statutory handling period 200 calendar days (initial review 105 + post-supplement review 95) | 200 days | 1-1.5 years | 8-11 months | Verified |
| No-predicate device(Registration of a device with no similar marketed product) Statutory handling period 220 calendar days (initial review 80 + post-supplement review 40 + advisory-committee review 100), covering in-vitro diagnostic medical devices as well | 220 days | 1-2 years | — | Verified |
Taiwan Medical Device Registration Process
Step-by-step TFDA registration process. Total estimated timeline: 3-7 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by TFDA. Appoint a Taiwan Agent.
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to TFDA including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksTFDA reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
80 daysIn-depth technical assessment of device safety and performance. TFDA may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, TFDA issues Taiwan market authorization certificate.
Abbreviated QMS review for USA/EU/Japan manufacturers
Eligibility: USA, EU, or Japan manufacturer
- Taiwan Agent (for foreign manufacturers)
- Traditional Chinese labeling
- Local testing from accredited labs
- QSD (Quality System Documentation)
- Post-approval change clocks (TFDA handling-period table, 2026-08-17): plant address/spec/model 90 days; name/IFU/packaging 60 days; new spec/model/efficacy 180 days; manufacturing-licence-number change 30 days; licence extension 60 days (180 days where safety-monitoring or post-market study reports are required); transfer 60 days; clinical trial application 90 days
Reviewed 2026-08-29. End-to-end totals remain planning estimates.